header logo image


Page 59«..1020..58596061..70..»

Archive for the ‘Gene therapy’ Category

Gene Therapy and Children – KidsHealth

Sunday, July 12th, 2015

Gene therapy carries the promise of cures for many diseases and for types of medical treatment that didn't seem possible until recently. With its potential to eliminate and prevent hereditary diseases such as cystic fibrosis and hemophilia and its use as a possible cure for heart disease, AIDS, and cancer, gene therapy is a potential medical miracle-worker.

But what about gene therapy for children? There's a fair amount of risk involved, so thus far only seriously ill kids or those with illnesses that can't be cured by standard medical treatments have been involved in clinical trials using gene therapy.

As those studies continue, gene therapy may soon offer hope for children with serious illnesses that don't respond to conventional therapies.

Our genes help make us unique. Inherited from our parents, they go far in determining our physical traits like eye color and the color and texture of our hair. They also determine things like whether babies will be male or female, the amount of oxygen blood can carry, and the likelihood of getting certain diseases.

Genes are composed of strands of a molecule called DNA and are located in single file within the chromosomes. The genetic message is encoded by the building blocks of the DNA, which are called nucleotides. Approximately 3 billion pairs of nucleotides are in the chromosomes of a human cell, and each person's genetic makeup has a unique sequence of nucleotides. This is mainly what makes us different from one another.

Scientists believe that every human has about 25,000 genes per cell. A mutation, or change, in any one of these genes can result in a disease, physical disability, or shortened life span. These mutations can be passed from one generation to another, inherited just like a mother's curly hair or a father's brown eyes. Mutations also can occur spontaneously in some cases, without having been passed on by a parent. With gene therapy, the treatment or elimination of inherited diseases or physical conditions due to these mutations could become a reality.

Gene therapy involves the manipulation of genes to fight or prevent diseases. Put simply, it introduces a "good" gene into a person who has a disease caused by a "bad" gene.

The two forms of gene therapy are:

Currently, gene therapy is done only through clinical trials, which often take years to complete. After new drugs or procedures are tested in laboratories, clinical trials are conducted with human patients under strictly controlled circumstances. Such trials usually last 2 to 4 years and go through several phases of research. In the United States, the U.S. Food and Drug Administration (FDA) must then approve the new therapy for the marketplace, which can take another 2 years.

The most active research being done in gene therapy for kids has been for genetic disorders (like cystic fibrosis). Other gene therapy trials involve children with severe immunodeficiencies, such as adenosine deaminase (ADA) deficiency (a rare genetic disease that makes kids prone to serious infection), sickle cell anemia, thalassemia, hemophilia, and those with familial hypercholesterolemia (extremely high levels of serum cholesterol).

Read this article:
Gene Therapy and Children - KidsHealth

Read More...

Challenges in Gene Therapy – Learn Genetics

Friday, July 3rd, 2015

HOME

Gene Therapy

Challenges in Gene Therapy?

Gene therapy is not a new field; it has been evolving for decades. Despite the best efforts of researchers around the world, however, gene therapy has seen only limited success. Why?

Gene therapy poses one of the greatest technical challenges in modern medicine. It is very hard to introduce new genes into cells of the body and keep them working. And there are financial concerns: Can a company profit from developing a gene therapy to treat a rare disorder? If not, who will develop and pay for these life-saving treatments?

Let's look at some of the main challenges in gene therapy.

For some disorders, gene therapy will work only if we can deliver a normal gene to a large number of cellssay several millionin a tissue. And they have to the correct cells, in the correct tissue. Once the gene reaches its destination, it must be activated, or turned on, to make the protein it encodes. And once it's turned on, it must remain on; cells have a habit of shutting down genes that are too active or exhibiting other unusual behaviors.

Introducing changes into the wrong cells Targeting a gene to the correct cells is crucial to the success of any gene therapy treatment. Just as important, though, is making sure that the gene is not incorporated into the wrong cells. Delivering a gene to the wrong tissue would be inefficient, and it could cause health problems for the patient.

For example, improper targeting could incorporate the therapeutic gene into a patient's germline, or reproductive cells, which ultimately produce sperm and eggs. Should this happen, the patient would pass the introduced gene to his or her children. The consequences would vary, depending on the gene.

Our immune systems are very good at fighting off intruders such as bacteria and viruses. Gene-delivery vectors must be able to avoid the body's natural surveillance system. An unwelcome immune response could cause serious illness or even death.

Read the original:
Challenges in Gene Therapy - Learn Genetics

Read More...

Gene Therapy – Nature

Thursday, July 2nd, 2015

Included in top indexing databases and has an impact factor of 3.104! The journal website is hosted on http://www.nature.com that gets 8.4 million page views per month Over 69,000 table of contents registrants and 82,706 page views across the Gene Therapy web site on average Easy and quick online submission system Rapid and rigorous peer review Advanced Article Preview (AAP) feature to be available from early March 2015 to all accepted original and review article authors. Accepted articles to be available online within 72 hours of acceptance into production! For further information on AAP please refer to About accepted article preview section Free manuscript deposition service to Pub Med Central on behalf of non-open access authors We regularly promote content alongside that of the Nature branded titles on our subject pages and in collections as well as via social media We also have a number of regional websites reaching a wide and varied audience demographic http://www.nature.com/regions Free online issue

Volume 22, No 7 July 2015 ISSN: 0969-7128 EISSN: 1476-5462

2014 Impact Factor 3.104* 117/289 Biochemistry & Molecular Biology 47/162 Biotechnology & Applied Microbiology 63/167 Genetics & Heredity 43/123 Medicine, Research & Experimental

Editors: J Glorioso, USA N Lemoine, UK

*2014 Journal Citation Reports Science Edition (Thomson Reuters, 2015)

Download the presentation from our How to Get Published Session. (281 kB)

Open

Gene Therapy now offers authors the option to publish their articles with immediate open access upon publication. Open access articles will also be deposited on PubMed Central at the time of publication and will be freely available immediately. Find out more from our FAQs page.

Reviews by top researchers in the field. See the recent Progress and Prospects articles.

Essential topics explored in depth in Gene Therapy Special Issues.

More:
Gene Therapy - Nature

Read More...

Gene therapy – Science Daily

Friday, May 22nd, 2015

Gene therapy is the insertion of genes into an individual's cells and tissues to treat a disease, and hereditary diseases in which a defective mutant allele is replaced with a functional one.

Although the technology is still in its infancy, it has been used with some success.

Antisense therapy is not strictly a form of gene therapy, but is a genetically-mediated therapy and is often considered together with other methods.

In most gene therapy studies, a "normal" gene is inserted into the genome to replace an "abnormal," disease-causing gene.

A carrier called a vector must be used to deliver the therapeutic gene to the patient's target cells.

Currently, the most common type of vectors are viruses that have been genetically altered to carry normal human DNA.

Viruses have evolved a way of encapsulating and delivering their genes to human cells in a pathogenic manner.

Scientists have tried to harness this ability by manipulating the viral genome to remove disease-causing genes and insert therapeutic ones.

Target cells such as the patient's liver or lung cells are infected with the vector.

The vector then unloads its genetic material containing the therapeutic human gene into the target cell.

Read the original here:
Gene therapy - Science Daily

Read More...

What is gene therapy? – Genetics Home Reference

Tuesday, May 19th, 2015

Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patients cells instead of using drugs or surgery. Researchers are testing several approaches to gene therapy, including:

Replacing a mutated gene that causes disease with a healthy copy of the gene.

Inactivating, or knocking out, a mutated gene that is functioning improperly.

Introducing a new gene into the body to help fight a disease.

Although gene therapy is a promising treatment option for a number of diseases (including inherited disorders, some types of cancer, and certain viral infections), the technique remains risky and is still under study to make sure that it will be safe and effective. Gene therapy is currently only being tested for the treatment of diseases that have no other cures.

MedlinePlus from the National Library of Medicine offers a list of links to information about genes and gene therapy.

Educational resources related to gene therapy are available from GeneEd.

The Genetic Science Learning Center at the University of Utah provides an interactive introduction to gene therapy and a discussion of several diseases for which gene therapy has been successful.

The Centre for Genetics Education provides an introduction to gene therapy, including a discussion of ethical and safety considerations.

KidsHealth from Nemours offers a fact sheet called Gene Therapy and Children.

Read the rest here:
What is gene therapy? - Genetics Home Reference

Read More...

What is Gene Therapy ? – Learn Genetics

Tuesday, May 19th, 2015

Gene therapy could be a way to fix a genetic problem at its source. By adding a corrected copy of a defective gene, gene therapy promises to help diseased tissues and organs work properly. This approach is different from traditional drug-based approaches, which may treat symptoms but not the underlying genetic problems.

Most commonly, gene therapy uses a vector, typically a virus, to deliver a gene to the cells where it's needed. Once it's inside, the cell's gene-reading machinery uses the information in the gene to build RNA and protein molecules. The proteins (or RNA) can then carry out their job in the cells.

But gene therapy is not a molecular bandage that will automatically fix any genetic problem. While many disorders or medical conditions can potentially be treated using gene therapy, others are not suitable for this approach. So what makes a condition a good candidate for gene therapy?

Could the condition be corrected by adding one or a few functional genes? For you to even consider gene therapy, the answer must be "yes." For instance, genetic disorders caused by mutations in single genes tend to be good candidates for gene therapy, while diseases involving many genes and environmental factors tend to be poor candidates.

Do you know which genes are involved? If you plan to treat a genetic flaw, you need to know which gene(s) to pursue. You must also have a DNA copy of the gene available in your laboratory.

Do you understand the biology of the disorder? To design the best possible approach, you need to learn all you can about how the gene factors into the disorder. For example, which tissues the disorder affects, what role the protein encoded by the gene plays within the cells of that tissue, and exactly how mutations in the gene affect the protein's function.

Will adding a normal copy of the gene fix the problem in the affected tissue? Or could getting rid of the defective gene fix it? Sometimes when a gene is defective, no functional protein is being made from it. In cases like these, adding a functional copy of the gene could correct the problem. But sometimes a defective gene codes for a protein that starts doing something it shouldn't or prevents another protein from doing its job. In order to correct the problem, you would need to get rid of the misbehaving protein.

Can you deliver the gene to cells of the affected tissue? The answer will come from several pieces of information, including the tissue's accessibility and molecular signatures.

APA format: Genetic Science Learning Center (2014, June 22) What is Gene Therapy?. Learn.Genetics. Retrieved May 19, 2015, from http://learn.genetics.utah.edu/content/genetherapy/gtintro/ MLA format: Genetic Science Learning Center. "What is Gene Therapy?." Learn.Genetics 19 May 2015 <http://learn.genetics.utah.edu/content/genetherapy/gtintro/> Chicago format: Genetic Science Learning Center, "What is Gene Therapy?," Learn.Genetics, 22 June 2014, <http://learn.genetics.utah.edu/content/genetherapy/gtintro/> (19 May 2015)

Link:
What is Gene Therapy ? - Learn Genetics

Read More...

Alliance for Cancer Gene Therapy (ACGT) Foundation

Tuesday, May 19th, 2015

Spotlight News Spot

April 28, 2015

ACGTs inaugural Innovative Leadership Award Gala raised $750,000 to fund cell and gene therapy research which aims to make cancer a manageable and treatable disease. The gala, honoring the significant contributions of Dr. Savio L.C. Woo has made to Read More

March 26, 2015

Emperor of All Maladies on PBS (CPTV) presented by documentary filmmaker Ken Burns, isbased on the2010 Pulitzer Prize-winning bookThe Emperor of All Maladies: A Biography of Cancerby Dr. Siddhartha Mukherjee. Among other scientists, doctors and patients, the programfeatured ACGT Researcher Read More

March 2, 2015

HBO Documentary Series, Vice, aired an episode on February 27th entitled, Killing Cancer, focusing on how different viruses are being used successfully as weapons to target cancer. The program focuses on 2013 ACGT Grantee Dr. John Bell, for his work Read More

January 16, 2015

In 2012, Bob Levis, an Allentown, Pennsylvania resident, believed he had come to the end of his life. Diagnosed in 2002 with chronic lymphocytic leukemia, the cancer had resisted every possible treatment and had infiltrated his bone marrow, paralyzing his Read More

March 16, 2014

Read more here:
Alliance for Cancer Gene Therapy (ACGT) Foundation

Read More...

Gene Therapy – Genetics Home Reference

Tuesday, May 19th, 2015

Please choose from the following list of questions for information about gene therapy, an experimental technique that uses genetic material to treat or prevent disease.

On this page:

Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patients cells instead of using drugs or surgery. Researchers are testing several approaches to gene therapy, including:

Replacing a mutated gene that causes disease with a healthy copy of the gene.

Inactivating, or knocking out, a mutated gene that is functioning improperly.

Introducing a new gene into the body to help fight a disease.

Although gene therapy is a promising treatment option for a number of diseases (including inherited disorders, some types of cancer, and certain viral infections), the technique remains risky and is still under study to make sure that it will be safe and effective. Gene therapy is currently only being tested for the treatment of diseases that have no other cures.

MedlinePlus from the National Library of Medicine offers a list of links to information about genes and gene therapy.

Educational resources related to gene therapy are available from GeneEd.

The Genetic Science Learning Center at the University of Utah provides an interactive introduction to gene therapy and a discussion of several diseases for which gene therapy has been successful.

Go here to read the rest:
Gene Therapy - Genetics Home Reference

Read More...

Hiro Nakauchi Definitive and Stem Cell & Gene Therapy for Child Health: Stanford Childx Conference – Video

Monday, April 27th, 2015


Hiro Nakauchi Definitive and Stem Cell Gene Therapy for Child Health: Stanford Childx Conference
Hiro Nakauchi discusses new stem cell therapies at the inaugural Childx Conference, 2015. Childx is a dynamic, TED-style conference designed to inspire innovation that improves pediatric and...

By: Stanford

Go here to see the original:
Hiro Nakauchi Definitive and Stem Cell & Gene Therapy for Child Health: Stanford Childx Conference - Video

Read More...

Nadia Rosenthal Definitive Stem Cell and Gene Therapy for Child Health: Stanford Childx Conference – Video

Monday, April 27th, 2015


Nadia Rosenthal Definitive Stem Cell and Gene Therapy for Child Health: Stanford Childx Conference
Nadia Rosenthal discusses the advances in regeneration and the future of regenerative health at the inaugural Childx Conference, 2015. Childx is a dynamic, TED-style conference designed to...

By: Stanford

Visit link:
Nadia Rosenthal Definitive Stem Cell and Gene Therapy for Child Health: Stanford Childx Conference - Video

Read More...

Sean Wu Definitive Stem Cell and Gene Therapy for Child Health: Stanford Childx Conference – Video

Monday, April 27th, 2015


Sean Wu Definitive Stem Cell and Gene Therapy for Child Health: Stanford Childx Conference
Sean Wu discusses his work engineering stem cells to cure heart disease at the inaugural Childx Conference, 2015. Childx is a dynamic, TED-style conference designed to inspire innovation that...

By: Stanford

Original post:
Sean Wu Definitive Stem Cell and Gene Therapy for Child Health: Stanford Childx Conference - Video

Read More...

Tony Oro Definitive and Stem Cell & Gene Therapy for Child Health: Stanford Childx Conference – Video

Monday, April 27th, 2015


Tony Oro Definitive and Stem Cell Gene Therapy for Child Health: Stanford Childx Conference
Tony Oro discusses therapeutic reprogramming at the inaugural Childx Conference, 2015. Childx is a dynamic, TED-style conference designed to inspire innovation that improves pediatric and...

By: Stanford

The rest is here:
Tony Oro Definitive and Stem Cell & Gene Therapy for Child Health: Stanford Childx Conference - Video

Read More...

Martin Andrews Definitive Stem Cell and Gene Therapy for Child Health: Stanford Childx Conference – Video

Monday, April 27th, 2015


Martin Andrews Definitive Stem Cell and Gene Therapy for Child Health: Stanford Childx Conference
Martin Andrews discusses bringing gene therapy to patients and targeting rare diseases at the inaugural Childx Conference, 2015. Childx is a dynamic, TED-style conference designed to inspire...

By: Stanford

Read the original here:
Martin Andrews Definitive Stem Cell and Gene Therapy for Child Health: Stanford Childx Conference - Video

Read More...

Matthew Porteus Definitive Stem Cell & Gene Therapy for Child Health: Stanford Childx Conference – Video

Sunday, April 26th, 2015


Matthew Porteus Definitive Stem Cell Gene Therapy for Child Health: Stanford Childx Conference
Matthew Porteus discusses correcting mutations that cause childhood genetic diseases at the inaugural Childx Conference, 2015. Childx is a dynamic, TED-style conference designed to inspire...

By: Stanford

Link:
Matthew Porteus Definitive Stem Cell & Gene Therapy for Child Health: Stanford Childx Conference - Video

Read More...

The Alpha Clinic for Cell Therapy and Innovation | City of Hope – Video

Friday, March 20th, 2015


The Alpha Clinic for Cell Therapy and Innovation | City of Hope
A new grant to City of Hope from the California Institute for Regenerative Medicine (CIRM) will make it possible for novel stem cell based therapies developed here at City of Hope to...

By: City of Hope

Read more:
The Alpha Clinic for Cell Therapy and Innovation | City of Hope - Video

Read More...

A Stem Cell Cure for Bubble Baby Disease (SCID) – Video

Wednesday, February 25th, 2015


A Stem Cell Cure for Bubble Baby Disease (SCID)
Visit: http://www.uctv.tv/) On November 18th, 2014, a UCLA research team led by Donald Kohn, M.D., announced a breakthrough gene therapy and stem cell cure ...

By: University of California Television (UCTV)

Originally posted here:
A Stem Cell Cure for Bubble Baby Disease (SCID) - Video

Read More...

UCLA Stem Cell Researchers Announce Gene Therapy Cure for 18 Bubble Baby Patients – Video

Monday, November 24th, 2014


UCLA Stem Cell Researchers Announce Gene Therapy Cure for 18 Bubble Baby Patients
Researchers at UCLA announced today that they had cured 18 children who were born with the so-called Bubble Baby disease, a genetic disorder that leaves the young sufferers without a working...

By: UCLA Eli Edythe Broad Center of Regenerative Medicine and Stem Cell Research

See the original post:
UCLA Stem Cell Researchers Announce Gene Therapy Cure for 18 Bubble Baby Patients - Video

Read More...

Stem Cell Cure for "Bubble Baby" Disease (SCID), Pioneered by UCLA’s Don Kohn – Video

Sunday, November 23rd, 2014


Stem Cell Cure for "Bubble Baby" Disease (SCID), Pioneered by UCLA #39;s Don Kohn
On November 18th, 2014, a UCLA research team led by Donald Kohn, M.D., announced a breakthrough gene therapy and stem cell cure for "bubble baby" disease, or severe combined ...

By: California Institute for Regenerative Medicine

See the original post:
Stem Cell Cure for "Bubble Baby" Disease (SCID), Pioneered by UCLA's Don Kohn - Video

Read More...

Stem Cells & FDA Oversight – Video

Saturday, October 25th, 2014


Stem Cells FDA Oversight
Celia Witten, M.D., Ph.D., Director, Office of Cellular, Tissue, Gene Therapy Center for Biologics Evaluation Research, Food Drug Administration (FDA) For more information on the 2014...

By: Alliance for Regenerative Medicine

View post:
Stem Cells & FDA Oversight - Video

Read More...

Four UCLA stem cell researchers receive CIRM Early Translational grants

Sunday, September 1st, 2013

Four researchers from UCLA’s Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have received Early Translational Research Awards totaling approximately $13 million from the California Institute for Regenerative Medicine, the state's stem cell agency. The UCLA researchers received four of the 12 total awards; no other institution received more than one.
 
The Independent Citizens Oversight Committee, CIRM’s governing body, announced at its Aug. 28 meeting in La Jolla, Calif., that grant recipients included Dr. Jerome Zack, professor of medicine and microbiology, immunology and molecular genetics; Dr. Robert Reiter, Bing Professor of Urologic Research; Dr. Donald Kohn, professor of pediatrics and microbiology, immunology and molecular genetics in th...

MedWorm Sponsor Message: Find the best Christmas presents and January Sales in the UK with this simple shopping directory.

Source:
http://www.medworm.com/index.php?rid=7551755&cid=c_449_44_f&fid=38766&url=http%3A%2F%2Fnewsroom.ucla.edu%2Fportal%2Fucla%2Ffour-prominent-ucla-stem-cell-248077.aspx%3Flink_page_rss%3D248077

Read More...

Page 59«..1020..58596061..70..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick